openPR Logo
Press release

Cryptococcosis Treatment Market 2026 Industry Overview, Evolution Growth Rate and Future Forecasts 2020-2026

09-16-2020 02:54 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Cryptococcosis Treatment Market

Cryptococcosis Treatment Market

Cryptococcosis or cryptococcal disease is a fungal disease, which in severe cases can be fatal. It is caused by either Cryptococcus neoformans or Cryptococcus gattii. Cryptococcosis is said to be acquired by inhaling contagious propagule from surroundings. Even though the accurate character of the contagious propagule is not known, the primary theory is the basidiospore produced in the course of sexual or asexual reproduction is the cause. Cryptococcosis disease symptoms include fatigue, fever, headache, blurred vision, dry cough, and confusion. Symptoms onset is often subacute, worsening progressively over more than a few weeks. The two key complications of the disease are meningitis (brain infection) and pulmonary infection or lung infection. The occurrence of cryptococcosis is increasing over the years for various reasons, such as increase in prevalence of AIDS as well as extended use of immunosuppressive drugs. These factors are likely to propel the growth of the overall cryptococcosis treatment market in the near future.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/147

According to a report by National Centre for Biotechnology Information, illnesses due to Cryptococcus fungi occur on a global scale and in an extensive range of hosts, starting from patients who are strictly immunosuppressed to patients with normal immune systems. The Centers for Disease Control and Prevention (CDC) states that around 1 million cryptococcosis cases arise throughout the globe, and it is anticipated that annually, the number of deaths associated with cryptococcosis is around 650,000. Most of the cases are reported among amongst patients with complex HIV disease. However, incidence rate is high amongst the recipients of solid organ transplant and patients getting exogenous immunosuppression. Cryptococcus occurs in those with acquired and innate immunodeficiency as well.

As the AIDS population is rising at a startling rate, the likelihood of occurrence of the disease is rising proportionately. Since cryptococcosis disease is communicable in nature, and it gets transmitted from one affected person to the next, persons suffering from the disease are expected to rise in the near future. Therefore, the cryptococcosis treatment market will also show a considerable growth.

Cryptococcosis Treatment Market Taxonomy

On the basis of type of treatment, global cryptococcosis treatment market is classified into:

Amphotericin B
Flucytosine
Fluconazole
Others

Rising prevalence of chronic diseases to fuel cryptococcosis treatment market growth

The major factor working for the increase of the worldwide cryptococcosis treatment market is the rising count of people being contaminated by the disease. As per UNAIDS, there is an estimated 36.7 million cases of AIDS in the world at the end of the year 2015. Rise in the prevalence of diseases such as AIDS will further amplify the demand for the cryptococcosis treatment. Cryptococcosis was classified as a rarely happening illness; however, now the disease is seen to be rising across the globe. Several governments are vastly interested in eliminating the disease altogether from their respective nations. The efforts put in by governments of various regions are encouraging the players in the global market to increase their overall spend on research and development activities, in order to get superior treatment alternatives. This will further aid the global market of cryptococcosis treatment to increase at a steady pace.

Increasing prevalence of cryptococcosis in Sub-Saharan Africa will drive the overall cryptococcosis treatment market growth

According to CDC, in 2009, there were an estimated 720,000 cases of HIV related cryptococcosis in the Sub-Saharan Africa, which is about three times the prevalence of the disease in all other parts of the world, combined. It is believed that the disease kills more people in this region than tuberculosis. Moreover, CDC also states that cryptococcosis is the fourth most fatal disease in the region. It is estimated to cause about 504,000 deaths per year. The occurrence of cryptococcosis in the region is growing at an alarming rate; hence, the market in this region is expected to grow at a significant rate over the forecast period.

Some of the major companies operating in the global cryptococcosis treatment market are Bristol-Myers Squibb Company, Sigmapharm Laboratories LLC, Janssen Biotech, Inc. (Johnson & Johnson), Novartis AG, Abbott Laboratories, Valeant Pharmaceuticals, Inc., Pfizer, Inc., and Glenmark Pharmaceuticals.

Get Instant Discount at: https://www.coherentmarketinsights.com/insight/request-discount/147

Key Developments

Major market players are involved in different business strategies such as gaining product approval from regulatory authorities, in order to gain competitive edge in the global market. For instance, in February 2019, Amplyx Pharmaceuticals, a U.S.-based pharmaceutical company, received orphan drug designation for APX001 from the U.S. Food and Drug Administration (FDA) Office of Orphan Product Development. This drug will be used for the treatment of cryptococcosis.
Key market players are focused on different business strategies such as product launches, in order to gain competitive edge in the global market. For instance, in January 2018, Lupin Limited, an Indian pharmaceutical company, launched generic version of Valeant Pharmaceutical International Inc.’s ‘Ancobon Capsules’. These capsules are indicated for infections caused by Cryptococcus.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cryptococcosis Treatment Market 2026 Industry Overview, Evolution Growth Rate and Future Forecasts 2020-2026 here

News-ID: 2135414 • Views: 141

More Releases from Coherent Market Insights

Respiratory Air Conditioning Devices Market See Incredible Growth 2022-2028 | Be …
Coherent Market Insights has released a new research study on the "Respiratory Air Conditioning Devices Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Respiratory Air Conditioning Devices Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Respiratory Air Conditioning Devices
Liquid Biopsy Market Expected to Expand at a Steady 2022-2028 | Biocept, Inc., Q …
Coherent Market Insights has released a new research study on the "Liquid Biopsy Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Liquid Biopsy Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Liquid Biopsy Market research report is an intelligence
Extracorporeal Membrane Oxygenation System Market Future Business Opportunities …
Coherent Market Insights has released a new research study on the "Extracorporeal Membrane Oxygenation System Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Extracorporeal Membrane Oxygenation System Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Extracorporeal Membrane Oxygenation System
Radiopharmaceuticals in Nuclear Medicine Market Huge Growth in Future Scope 2022 …
Coherent Market Insights has released a new research study on the "Radiopharmaceuticals in Nuclear Medicine Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Radiopharmaceuticals in Nuclear Medicine Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Radiopharmaceuticals in Nuclear Medicine

All 5 Releases


More Releases for Cryptococcosis

Cryptococcosis Treatment Market Opportunity Analysis, 2018-2026
Cryptococcosis or cryptococcal disease is a fungal disease, which in severe cases can be fatal. It is caused by either Cryptococcus neoformans or Cryptococcus gattii. Cryptococcosis is said to be acquired by inhaling contagious propagule from surroundings. Even though the accurate character of the contagious propagule is not known, the primary theory is the basidiospore produced in the course of sexual or asexual reproduction is the cause. Cryptococcosis disease symptoms
Cryptococcosis Market: Report Scope and Market Segmentation
Transparency Market Research reveals in a recently released market intelligence report that leading players from the global cryptococcosis market are likely to participate in a wave of mergers and acquisitions in all key regions of the market over the coming years. Business conglomerates have significant investments in the recent past to bring to fruition their research and development efforts for new drugs and are interested in expanding their distribution chain
Cryptococcosis Pharmaceutical and Healthcare Pipeline Review H1
Summary Cryptococcosis is infection caused by Cryptococcus neoformans fungus. Symptoms include cough, fatigue, fever, head ache, nausea and skin rashes. Predisposing factors are most often seen in people with a weakened immune system, such as those with HIV infection, taking high doses of corticosteroid medications, cancer chemotherapy, or who have Hodgkin's disease. Treatment includes anti fungal drugs. GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3010379-cryptococcosis-pipeline-review-h1-2018 Report Highlights Pharmaceutical and Healthcare latest pipeline guide Cryptococcosis - Pipeline
Cryptococcosis Market Size, Status and Forecast to 2024
Transparency Market Research reveals in a recently released market intelligence report that leading players from the global cryptococcosis market are likely to participate in a wave of mergers and acquisitions in all key regions of the market over the coming years. Business conglomerates have significant investments in the recent past to bring to fruition their research and development efforts for new drugs and are interested in expanding their distribution chain
Cryptococcosis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Cryptococcosis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cryptococcosis - Pipeline Review, H2 2017, provides an overview of the Cryptococcosis (Infectious Disease) pipeline landscape. Cryptococcosis is infection caused by Cryptococcus neoformans fungus. Symptoms include cough, fatigue, fever, head ache, nausea and skin rashes. Predisposing factors
Cryptococcosis Market Research Report Forecast to 2024
Publisher reveals in a recently released market intelligence report that leading players from the global cryptococcosis market are likely to participate in a wave of mergers and acquisitions in all key regions of the market over the coming years. Business conglomerates have significant investments in the recent past to bring to fruition their research and development efforts for new drugs and are interested in expanding their distribution chain to broader